ID: ALA4637527

Max Phase: Preclinical

Molecular Formula: C19H18ClNO2

Molecular Weight: 292.36

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  COc1ccc2c(c1)CC[n+]1cc3c(OC)cccc3cc1-2.[Cl-]

Standard InChI:  InChI=1S/C19H18NO2.ClH/c1-21-15-6-7-16-14(10-15)8-9-20-12-17-13(11-18(16)20)4-3-5-19(17)22-2;/h3-7,10-12H,8-9H2,1-2H3;1H/q+1;/p-1

Standard InChI Key:  OZPDXBXSBWNOGC-UHFFFAOYSA-M

Associated Targets(Human)

KM12C 20 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Retinoid X receptor alpha 3637 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

HCT-116 91556 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SW-620 52400 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

MEF 1005 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 292.36Molecular Weight (Monoisotopic): 292.1332AlogP: 3.37#Rotatable Bonds: 2
Polar Surface Area: 22.34Molecular Species: NEUTRALHBA: 2HBD: 0
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: CX LogP: -0.91CX LogD: -0.91
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.68Np Likeness Score: 0.85

References

1. Xu B, Jiang X, Xiong J, Lan J, Tian Y, Zhong L, Wang X, Xu N, Cao H, Zhang W, Zhang H, Hong X, Zhan YY, Zhang Y, Hu T..  (2020)  Structure-Activity Relationship Study Enables the Discovery of a Novel Berberine Analogue as the RXRα Activator to Inhibit Colon Cancer.,  63  (11): [PMID:32391701] [10.1021/acs.jmedchem.0c00088]

Source